Comprehensive Cancer Center Mainfranken, University Hospital Würzburg
The university where Röntgen discovered X-rays, now a world centre for CAR-T and bispecific antibodies in multiple myeloma under Hermann Einsele.
Overview
Wilhelm Conrad Röntgen discovered X-rays at Würzburg in 1895, the founding moment of radiation medicine. Today the CCC Mainfranken is a German Cancer Aid Oncology Center of Excellence and, with Erlangen, Regensburg and Augsburg, one of the National Center for Tumor Diseases sites (NCT WERA) since 2023. Hermann Einsele's Department of Internal Medicine II has been a leading European site for BCMA-directed CAR-T and bispecific antibodies in myeloma, including the CARTITUDE and MajesTEC programmes, and was among the first in Europe to treat patients with these agents. The centre also has strong programmes in stem cell transplantation, neuro-oncology, nuclear medicine and theranostics, and translational immunology.
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-22.
Matched to Universitätsklinikum Würzburg, including child institutions. 779 works · 9,936 citations · 71% open access · 11% clinical trials · 1% reviews.
- Michael Hudecek98 works
- Hermann Einsele78 works
- Max S. Topp43 works
- Bastian Schilling39 works
- Volker Kunzmann33 works
- Anja Gesierich30 works
- Andreas Vollmer29 works
- Dirk Schadendorf28 works
- Martin Wermke28 works
- Babak Saravi28 works
- Multiple myeloma CAR-T and bispecifics
- Stem cell transplantation
- Theranostics
- NCT WERA
Similar pages
not linked directly; found by shared links- InstitutionKing Faisal Specialist Hospital and Research Centre
Shares Diffuse large B-cell lymphoma, Radioligand therapy (beta emitters).
- InstitutionUniversity Hospital Zurich / Comprehensive Cancer Center Zurich
Shares Diffuse large B-cell lymphoma, Radioligand therapy (beta emitters).
- BottleneckManufacturing cost and time for living and radioactive medicines
Shares Diffuse large B-cell lymphoma, Radioligand therapy (beta emitters).